Mechanisms and use of calcium-sensitizing agents in the failing heart

[51] Papp Z, 2005, CARDIOVASC DRUG REV, V23, P71

[52] Novel myofilament Ca2+-sensitizing property of xanthine oxidase inhibitors [J]. CIRCULATION RESEARCH, 1998, 83 (04) : 423 - 430

[53] HEMODYNAMIC, NEUROHUMORAL, AND MYOCARDIAL ENERGETIC EFFECTS OF PIMOBENDAN, A NOVEL CALCIUM-SENSITIZING COMPOUND, IN PATIENTS WITH MILD-TO-MODERATE HEART-FAILURE [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 24 (05) : 730 - 739

[54] Molecular mechanism of levosimendan action: an update [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (09) : 1011 - 1015

[55] Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart [J]. CIRCULATION RESEARCH, 2002, 90 (03) : 297 - 304

[56] MCI-154 INCREASES CA2+ SENSITIVITY OF RECONSTITUTED THIN FILAMENT - A STUDY USING A NOVEL IN-VITRO MOTILITY ASSAY TECHNIQUE [J]. CIRCULATION RESEARCH, 1995, 76 (04) : 626 - 633

[57] PIMOBENDAN DIRECTLY SENSITIZES RECONSTITUTED THIN FILAMENT TO SLIDE ON CARDIAC MYOSIN [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 290 (01): : 55 - 59

[58] Improved mechanoenergetics and cardiac rest and reserve function of in vivo failing heart by calcium sensitizer EMD-57033 [J]. CIRCULATION, 2000, 101 (09) : 1040 - 1048

[59] Relaxation effect of CGP-48506, EMD-57033, and dobutamine in ejecting and isovolumically beating rabbit hearts [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (06): : H2708 - H2720

[60] Augmented systolic response to the calcium sensitizer EMD-57033 in a transgenic model with troponin I truncation [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (05): : H1785 - H1792

[51] Papp Z, 2005, CARDIOVASC DRUG REV, V23, P71

[52] Novel myofilament Ca2+-sensitizing property of xanthine oxidase inhibitors [J]. CIRCULATION RESEARCH, 1998, 83 (04) : 423 - 430

[53] HEMODYNAMIC, NEUROHUMORAL, AND MYOCARDIAL ENERGETIC EFFECTS OF PIMOBENDAN, A NOVEL CALCIUM-SENSITIZING COMPOUND, IN PATIENTS WITH MILD-TO-MODERATE HEART-FAILURE [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 24 (05) : 730 - 739

[54] Molecular mechanism of levosimendan action: an update [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (09) : 1011 - 1015

[55] Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart [J]. CIRCULATION RESEARCH, 2002, 90 (03) : 297 - 304

[56] MCI-154 INCREASES CA2+ SENSITIVITY OF RECONSTITUTED THIN FILAMENT - A STUDY USING A NOVEL IN-VITRO MOTILITY ASSAY TECHNIQUE [J]. CIRCULATION RESEARCH, 1995, 76 (04) : 626 - 633

[57] PIMOBENDAN DIRECTLY SENSITIZES RECONSTITUTED THIN FILAMENT TO SLIDE ON CARDIAC MYOSIN [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 290 (01): : 55 - 59

[58] Improved mechanoenergetics and cardiac rest and reserve function of in vivo failing heart by calcium sensitizer EMD-57033 [J]. CIRCULATION, 2000, 101 (09) : 1040 - 1048

[59] Relaxation effect of CGP-48506, EMD-57033, and dobutamine in ejecting and isovolumically beating rabbit hearts [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (06): : H2708 - H2720

[60] Augmented systolic response to the calcium sensitizer EMD-57033 in a transgenic model with troponin I truncation [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (05): : H1785 - H1792